Pregabalin add-on for drug-resistant focal epilepsy

This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...

The King Review – where to now?

As PSA National President, I will continue to work with the government and other stakeholders to unlock opportunities for pharmacists to realise their full...

Pharmacy profession calls for progress on prescribing

Momentum for pharmacist prescribing continues to grow, with a third of participants at a recent forum calling for the profession to move forward with...

Help patients beat the extreme heat

Australia is in the midst of a record-breaking heatwave – with Western Australia, South Australia, Tasmania, Victoria, the ACT and NSW all reaching maximum...

Pharmacists’ true value not yet realised: PSA

Pharmacists are the healthcare professionals best placed to address the crisis in medicine safety in Australia, and could contribute to cost savings of $1.4...

Opioids, antidepressants and the risk of hip fracture

A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...